Vioxx testimony focuses on discrepancy in letter

In testimony earlier today, Attorney Mark Lanier was able to hammer home discrepancies about Mercks letter it sent to doctors on the risk of Vioxx.

The focus was a 2001 letter in which it appears the risks of cardiac incidents was substantially understated according to Merck's own internal study, but yet was sent to doctors, most notably the plaintiffs doctor in this case.

Interesting reading regarding the tactics being used. The press coverage has been outstanding so far in both the New York Times and The Wall Street Journal.

Posted on July 20, 2005 .